Liposomal hemp extract for the management of cachexia

E. Blair, Alan L. Miller
{"title":"Liposomal hemp extract for the management of cachexia","authors":"E. Blair, Alan L. Miller","doi":"10.31989/bchd.v6i4.1007","DOIUrl":null,"url":null,"abstract":"Background: The onset of cachexia, a body-wasting condition, is an ominous sign— it occurs in up to 80% of patients with cancer and is the ultimate cause of death in up to 20% of these patients. Moreover, cachexia can make treatment for cancer more difficult and less effective. With no approved treatment for cachexia, some patients have experimented with cannabis to increase their appetite. Findings on the use of cannabis as a treatment for cachexia have shown some promise; however, well-designed clinical trials of cannabinoids are necessary to provide guidance to both physicians and patients regarding formulation and dose.Objective: The aim of this studyas to use a mouse model to examine the effects of a liposomal cannabinoid-containing hemp extract on cancer-related cachexia.Method: Bagg Albino c mice were inoculated with colon 26 tumor cells and followed until they developed signs and symptoms of cachexia. Upon onset of cachexia, the mice received a single dose of either 0.2 mg or 1 mg of a delta-9-tetrahydrocannabinol-free (THC-free) liposomal hemp extract containing 20% cannabidiol (CBD) and other cannabinoids. A control group received no treatment. Another dose of 0.2 mg liposomal hemp extract was given after a few days to mice that failed to respond to treatment, or to mice that initially responded to treatment but began to lose weight again after stabilizing.Results: Of the 7 mice who were given 1 mg liposomal hemp extract, 4 gained weight and survived. Of the 7 mice who were given 0.2 mg of liposomal hemp extract, 2 gained weight and survived. Only 1 of the 9 mice in the control group survived.Conclusion: The findings suggest the beneficial effects of liposomal hemp extract in treating and, in some cases, reversing cachexia and improving survival in a mouse model. This study revealed promising results that should be replicated in human subjects to test if similar results are seen and to determine an optimal dose.Keyword: Hemp, Cannabinoids, Liposomal, Cancer, Cachexia, Mouse","PeriodicalId":93079,"journal":{"name":"Bioactive compounds in health and disease","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioactive compounds in health and disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31989/bchd.v6i4.1007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The onset of cachexia, a body-wasting condition, is an ominous sign— it occurs in up to 80% of patients with cancer and is the ultimate cause of death in up to 20% of these patients. Moreover, cachexia can make treatment for cancer more difficult and less effective. With no approved treatment for cachexia, some patients have experimented with cannabis to increase their appetite. Findings on the use of cannabis as a treatment for cachexia have shown some promise; however, well-designed clinical trials of cannabinoids are necessary to provide guidance to both physicians and patients regarding formulation and dose.Objective: The aim of this studyas to use a mouse model to examine the effects of a liposomal cannabinoid-containing hemp extract on cancer-related cachexia.Method: Bagg Albino c mice were inoculated with colon 26 tumor cells and followed until they developed signs and symptoms of cachexia. Upon onset of cachexia, the mice received a single dose of either 0.2 mg or 1 mg of a delta-9-tetrahydrocannabinol-free (THC-free) liposomal hemp extract containing 20% cannabidiol (CBD) and other cannabinoids. A control group received no treatment. Another dose of 0.2 mg liposomal hemp extract was given after a few days to mice that failed to respond to treatment, or to mice that initially responded to treatment but began to lose weight again after stabilizing.Results: Of the 7 mice who were given 1 mg liposomal hemp extract, 4 gained weight and survived. Of the 7 mice who were given 0.2 mg of liposomal hemp extract, 2 gained weight and survived. Only 1 of the 9 mice in the control group survived.Conclusion: The findings suggest the beneficial effects of liposomal hemp extract in treating and, in some cases, reversing cachexia and improving survival in a mouse model. This study revealed promising results that should be replicated in human subjects to test if similar results are seen and to determine an optimal dose.Keyword: Hemp, Cannabinoids, Liposomal, Cancer, Cachexia, Mouse
脂质体大麻提取物治疗恶病质
背景:恶病质是一种全身疼痛的疾病,它的发作是一个不祥的预兆——它发生在高达80%的癌症患者中,是高达20%的患者死亡的最终原因。此外,恶病质会使癌症的治疗变得更加困难和无效。由于没有获得批准的恶病质治疗方法,一些患者尝试使用大麻来增加食欲。使用大麻治疗恶病质的研究结果显示出一些前景;然而,精心设计的大麻素临床试验对于为医生和患者提供有关配方和剂量的指导是必要的。目的:利用小鼠模型研究含大麻素大麻提取物脂质体对癌症相关恶病质的影响。方法:用结肠26肿瘤细胞接种Bagg Albino c小鼠,观察其恶病质的体征和症状。恶病质发作时,小鼠接受单剂量0.2mg或1mg的含有20%大麻二酚(CBD)和其他大麻素的delta-9-四氢大麻酚(不含THC)脂质体大麻提取物。对照组未接受任何治疗。几天后,将另一剂量的0.2mg脂质体大麻提取物给予对治疗没有反应的小鼠,或给予最初对治疗有反应但在稳定后又开始减肥的小鼠。结果:在给予1mg大麻脂质体提取物的7只小鼠中,4只体重增加并存活。在给予0.2mg脂质体大麻提取物的7只小鼠中,2只体重增加并存活。对照组的9只小鼠中只有1只存活下来。结论:研究结果表明,大麻提取物脂质体在治疗小鼠恶病质和提高存活率方面具有有益作用,在某些情况下,还具有逆转恶病质的作用。这项研究揭示了有希望的结果,应该在人类受试者身上复制,以测试是否出现类似的结果,并确定最佳剂量。关键词:大麻,大麻酚,脂质体,癌症,恶病质,小鼠
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信